Answers are grounded in this paper and cite their sources.
Narrative review proposes a systematic tapering strategy for effective inpatient benzodiazepine withdrawal management.
BACKGROUND: Benzodiazepines are widely prescribed, yet long-term use carries risks of adverse clinical outcomes and challenging withdrawal syndromes. Although gradual outpatient tapering remains the standard recommendation for discontinuation, a subset of patients may require more rapid discontinuation in inpatient settings due to complex factors, such as misuse of multiple substances, prior failed tapering attempts, or co-occurring medical and psychiatric conditions. METHODS: This narrative review synthesizes contemporary literature on inpatient benzodiazepine withdrawal. We conducted a targeted review of clinical studies, guidelines, and expert opinion pieces published from 2000-2024, with a focus on real-world applicability. DISCUSSION: We assess recent findings and best-practice recommendations on benzodiazepine discontinuation and propose a systematic, individualized tapering strategy to guide inpatient withdrawal management. Additionally, we review medication selection, long-acting benzodiazepines and phenobarbital protocols, adjunctive pharmacotherapy, and behavioral interventions while emphasizing co-occurring disorders, risk management, and protracted withdrawal symptoms. CONCLUSION: Our proposed approach may enhance systematic and safe management of inpatient benzodiazepine withdrawal, especially for complex patient populations.
No takes yet. Share an insight, caveat, or question.
Karavolis et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: